Published in Appl Microbiol on March 01, 1973
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Rapid method for identification of gram-negative, nonfermentative bacilli. J Clin Microbiol (1976) 3.24
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate. Appl Environ Microbiol (1984) 1.69
Identification of Neisseria by electron capture gas-liquid chromatography of metabolites in a chemically defined growth medium. J Clin Microbiol (1977) 1.48
Characterization of some groups of gram-negative nonfermentative bacteria by the carbon source alkalinization technique. J Clin Microbiol (1981) 1.37
Pseudomonas cepacia strains isolated from water reservoirs of unheated nebulizers. J Clin Microbiol (1976) 1.29
Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun (1990) 1.27
Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride. Appl Environ Microbiol (1979) 1.22
Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia. Infect Immun (1983) 1.19
Bacteriological evaluation of an ultra-pure water-distilling system. Appl Microbiol (1975) 1.01
Factors influencing detection and enumeration of Pseudomonas aeruginosa by most-probable-number and membrane filtration techniques. Appl Microbiol (1975) 0.97
Factors that influence microbial contamination of fluids associated with hemodialysis machines. Appl Microbiol (1974) 0.93
Distribution of bacteria within operating laboratory water purification systems. Appl Environ Microbiol (1993) 0.86
Plasmids of Pseudomonas cepacia strains of diverse origins. Appl Environ Microbiol (1991) 0.86
Selective nonroutine microbial surveillance of in-use hospital nebulizers by aerosol entrapment and direct sampling analyses of solutions in reservoirs. J Clin Microbiol (1980) 0.82
Limulus amoebocyte lysate and direct sampling methods for surveillance of operating nebulizers. Appl Environ Microbiol (1981) 0.79
Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride. MBio (2016) 0.79
Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride. J Ind Microbiol Biotechnol (2015) 0.79
Photoreactivation of Pseudomonas cepacia after ultraviolet exposure: a potential source of contamination in ultraviolet-treated waters. J Clin Microbiol (1975) 0.78
Microbiological assessment of 24- and 48-h changes and management of semiclosed circuits from ventilators in a neonatal intensive care unit. J Clin Microbiol (1986) 0.78
Evaluation of liquid and solid culture media for the recovery and enrichment of Burkholderia cenocepacia from distilled water. J Ind Microbiol Biotechnol (2014) 0.76
Pedobacter hainanensis sp. nov., isolated from seaside soil. Curr Microbiol (2013) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
The aerobic pseudomonads: a taxonomic study. J Gen Microbiol (1966) 57.28
Outbreak of hospital infection caused by contaminated autoclaved fluids. Lancet (1972) 6.85
Pseudomonas aeruginosa: growth in distilled water from hospitals. Science (1971) 3.82
Colonization and infection with Pseudomonas cepacia. J Infect Dis (1972) 2.91
Wound infection with Pseudomonas multivorans. A water-borne contaminant of disinfectant solutions. Lancet (1970) 2.89
Contamination of hospital disinfectants with Pseudomonas species. Br Med J (1967) 2.60
Factors affecting comparative resistance of naturally occurring and subcultured Pseudomonas aeruginosa to disinfectants. Appl Microbiol (1972) 2.47
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1. N Engl J Med (1970) 2.29
Postoperative urinary-tract infections caused by contaminated irrigating fluid. Lancet (1966) 2.02
Identification of Pseudomonas species isolated from hospital environment and human sources. Appl Microbiol (1968) 2.00
Hospital infection by Pseudomonas cepacia. Lancet (1971) 1.91
Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit. Lancet (1971) 1.78
A combination medium for demonstrating starch and gelatin hydrolysis. Am J Med Technol (1968) 1.28
Characterization of EO-1 strains (Pseudomonas kingii) isolated from clinical specimens and the hospital environment. Appl Microbiol (1970) 1.15
Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med (1999) 6.45
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Pseudomonas aeruginosa: growth in distilled water from hospitals. Science (1971) 3.82
Use of laminar air-flow equipment in microbiology. Appl Microbiol (1968) 3.79
Use of ultrasonic energy in assessing microbial contamination on surfaces. Appl Microbiol (1967) 3.46
Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med (2001) 3.33
Microbiological sampling of surfaces. J Appl Bacteriol (1968) 3.18
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation (2001) 3.15
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med (2001) 3.02
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol (1978) 2.64
Survival of hepatitis B virus after drying and storage for one week. Lancet (1981) 2.60
Feasibility of using ultrasonics for removing viable microorganisms from surfaces. Contam Control (1967) 2.54
Comparative levels and types of microbial contamination detected in industrial clean rooms. Appl Microbiol (1966) 2.53
Factors affecting comparative resistance of naturally occurring and subcultured Pseudomonas aeruginosa to disinfectants. Appl Microbiol (1972) 2.47
The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med (1993) 2.41
Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis (1985) 2.39
Acanthamoeba keratitis in soft contact lens wearers. A case-control study. JAMA (1987) 2.38
Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol (1987) 2.31
Gram-negative water bacteria in hemodialysis systems. Health Lab Sci (1975) 2.28
Dry-heat inactivation kinetics of naturally occurring spore populations. Appl Microbiol (1970) 2.27
Microbiologic assay of space hardware. Environ Biol Med (1971) 1.90
A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol (2000) 1.86
Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion (2001) 1.81
Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun (1990) 1.80
Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med (1987) 1.74
Relative frequency distribution of d(125 C) values for spore isolates from the mariner-Mars 1969 spacecraft. Appl Microbiol (1971) 1.72
Decontaminated single-use devices: an oxymoron that may be placing patients at risk for cross-contamination. Infect Control Hosp Epidemiol (2001) 1.70
Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol (1988) 1.67
Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics (2001) 1.66
Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J Clin Microbiol (1983) 1.66
Viral hepatitis B: aspects of environmental control. Health Lab Sci (1977) 1.64
Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol (1997) 1.63
Molecular subtyping of Clostridium perfringens by pulsed-field gel electrophoresis to facilitate food-borne-disease outbreak investigations. J Clin Microbiol (1999) 1.60
Microbiological evaluation of the vacuum probe surface sampler. Appl Microbiol (1969) 1.59
Transmission of blood-borne pathogens during sports: risk and prevention. Ann Intern Med (1995) 1.59
An epidemiologic approach to low-level radium 226 exposure. Public Health Rep (1966) 1.58
Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infect Control Hosp Epidemiol (1991) 1.49
Survival of hepatitis A virus in feces after drying and storage for 1 month. J Clin Microbiol (1982) 1.46
CDC Guideline for Handwashing and Hospital Environmental Control, 1985. Infect Control (1986) 1.41
Intrinsic bacterial contamination of a commercial iodophor solution: investigation of the implicated manufacturing plant. Appl Environ Microbiol (1984) 1.40
Biological indicators for a liquid chemical sterilizer: a solution to the instrument reprocessing problem? Infect Control Hosp Epidemiol (1993) 1.39
Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol (1988) 1.37
Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr (1994) 1.36
Whirlpool spa-associated infections: are we really in hot water? Am J Public Health (1984) 1.36
A microbiological assay technique for hands. Health Lab Sci (1973) 1.36
Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol (1989) 1.34
Efficacy of chemical dosing methods for isolating nontuberculous mycobacteria from water supplies of dialysis centers. Appl Environ Microbiol (1988) 1.33
Long-term outcomes of patients receiving percutaneous endoscopic gastrostomy tubes. J Gen Intern Med (1996) 1.32
Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol (1976) 1.30
Determining the significance of coagulase-negative staphylococci isolated from blood cultures at a community hospital: a role for species and strain identification. Infect Control Hosp Epidemiol (2000) 1.29
A combination medium for demonstrating starch and gelatin hydrolysis. Am J Med Technol (1968) 1.28
Microbial contamination of renal dialysis systems and associated health risks. Trans Am Soc Artif Intern Organs (1974) 1.27
Factors influencing the occurrence of high numbers of iodine-resistant bacteria in iodinated swimming pools. Appl Microbiol (1966) 1.27
Microbiologic indicators of health risks associated with swimming. Am J Public Health (1985) 1.27
The Veterans Affairs medical care system: hospital and clinic utilization statistics for 1994. Med Care (1998) 1.25
Evaluation of a finger prick blood collection method for the seroepidemiology of hepatitis B. Bull World Health Organ (1978) 1.25
Pyrogenic reactions during haemodialysis caused by extramural endotoxin. Lancet (1975) 1.24
Iodine--champagne in a tin cup. Infect Control (1982) 1.24
Bacillus sp. ATCC 27380: a spore with extreme resistance to dry heat. Appl Microbiol (1973) 1.22
Factors associated with Pseudomonas pickettii intrinsic contamination of commercial respiratory therapy solutions marketed as sterile. Appl Environ Microbiol (1985) 1.20
A multistate nosocomial outbreak of Ralstonia pickettii colonization associated with an intrinsically contaminated respiratory care solution. Clin Infect Dis (1999) 1.19